Chapter 12 Buprenorphine is increasingly used in clinical practice. In addition to parenteral administration, it can be administered via the oral transmucosal route (OTM). This route has been demonstrated to provide analgesia in the cat at 0.02 mg/kg (Robertson et al, 2005). However, in the dog this dose has lower bioavailability and seems to provide little analgesia. A higher OTM dose (0.12 mg/kg) has greater bioavailability, and in a study of dogs undergoing ovariohysterectomy (OVH) it appeared to be an alternative for postoperative pain management when given immediately before anesthetic induction (Ko et al, 2011). However, drug cost and the volume that must be administered (in bigger dogs) may be concerns. Buprenorphine SR is an injectable, sustained-released (polymer) formulation that is designed to release buprenorphine over a 72-hour period; in cats undergoing OVH this appeared to have an efficacy and adverse effect profile comparable to twice-daily OTM administration of buprenorphine (Catbagan et al, 2011). There have been anecdotal reports of some dogs exhibiting dysphoria and anorexia when buprenorphine SR is used at higher doses. Side effects of NSAIDs include gastrointestinal ulceration, renal damage, and a decrease in platelet function. Accordingly, obvious contraindications to NSAIDs include gastrointestinal ulceration or bleeding, platelet dysfunction, renal dysfunction, and concurrent corticosteroid use. Furthermore, hypotension, intravascular volume depletion (from vomiting, diarrhea, hemorrhage, or other fluid losses), and congestive heart failure can also constitute relative or absolute contraindications because these disorders can compromise function of the kidneys and gastrointestinal tract. Thus NSAIDs are most safely used in normovolemic, hemodynamically stable patients. However, carprofen did not cause clinically relevant adverse effects in dogs anesthetized for fracture repair, even when it was administered before surgery or given to patients with trauma-induced alterations in renal function or hemostasis (Bergmann et al, 2005).
Analgesia of the Critical Patient
Opioids
Nonsteroidal Antiinflammatory Drugs
Analgesia of the Critical Patient
Only gold members can continue reading. Log In or Register a > to continue